Accustem Sciences (ACUT) Total Debt Growth (3y) (2024 - 2025)

Accustem Sciences (ACUT) Total Debt Growth (3y) (2024 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt Growth (3y) (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.08%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	19.52%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-22.87%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-22.30%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	4.76%
10	Accustem Sciences	2.57 Mn	2.56 Mn	-	-40.53%

Download Data